Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study

PURPOSEBreast cancer (BC) is the most common malignancy among women in India and globally. Given the high survivorship, understanding the evolution of health-related quality of life (HRQoL) is crucial, yet comprehensive longitudinal studies from India are lacking.PATIENTS AND METHODSThis prospective...

Full description

Saved in:
Bibliographic Details
Main Authors: Suman Ghosh, Tabassum Wadasadawala, Sanjay Mohanty, Rajiv Sarin, Vani Parmar, Sudeep Gupta
Format: Article
Language:English
Published: American Society of Clinical Oncology 2025-04-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO-24-00507
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849700527399501824
author Suman Ghosh
Tabassum Wadasadawala
Sanjay Mohanty
Rajiv Sarin
Vani Parmar
Sudeep Gupta
author_facet Suman Ghosh
Tabassum Wadasadawala
Sanjay Mohanty
Rajiv Sarin
Vani Parmar
Sudeep Gupta
author_sort Suman Ghosh
collection DOAJ
description PURPOSEBreast cancer (BC) is the most common malignancy among women in India and globally. Given the high survivorship, understanding the evolution of health-related quality of life (HRQoL) is crucial, yet comprehensive longitudinal studies from India are lacking.PATIENTS AND METHODSThis prospective observational study included 500 patients with BC registered between June 2019 and March 2022. HRQoL was assessed at pretreatment, treatment completion, and 6-month follow-up using European Organisation for Research and Treatment of Cancer (EORTC)-QLQ-C30, EORTC-QLQ-BR-23, and EQ-5D-5L tools. A linear mixed-effects model analyzed HRQoL trajectories and predictors.RESULTSThe median patient age was 46 years, with 60.8% presenting with locally advanced disease; all patients underwent multimodal therapy, comprising surgery (57% mastectomy), chemotherapy (95%), and radiotherapy (RT; 77%). Pretreatment global QoL scores were influenced by age (younger fared better, P = .003), stage (P = .027), and social displacement (P = .038). Longitudinal assessment revealed a small decline in global QoL (–2.1) and EQ-VAS (–1.9), along with meaningful improvements in social (+12.8), cognitive (+4.3), and role function (+7.3). Symptom burden significantly decreased, except for deterioration in body image (–7) and sexual enjoyment (–16). Younger patients had slower recovery in physical (P = .003) and social function (P = .05), while school education and financial independence positively influenced QoL variation. Social displacement affected trajectories of QoL (P = .017), role (P = .032), and social function (P = .024). Extent of surgery and RT did not affect overall HRQoL trends, although RT recipients reported more fatigue (P = .029).CONCLUSIONTo our knowledge, this is the first longitudinal HRQoL study in Indian patients with BC, showing significant improvement in most functional domains at early survivorship. Sociodemographic factors, such as age, social displacement, education, and financial independence, rather than treatment modalities, were stronger predictors of HRQoL. Longer follow-up is needed for a more comprehensive assessment.
format Article
id doaj-art-7b21c258b34142d5a6dc33cbd5e0665f
institution DOAJ
issn 2687-8941
language English
publishDate 2025-04-01
publisher American Society of Clinical Oncology
record_format Article
series JCO Global Oncology
spelling doaj-art-7b21c258b34142d5a6dc33cbd5e0665f2025-08-20T03:18:13ZengAmerican Society of Clinical OncologyJCO Global Oncology2687-89412025-04-011110.1200/GO-24-00507Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal StudySuman Ghosh0Tabassum Wadasadawala1Sanjay Mohanty2Rajiv Sarin3Vani Parmar4Sudeep Gupta5Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, IndiaTata Memorial Centre, Homi Bhabha National Institute, Mumbai, IndiaInternational Institute for Population Sciences, Mumbai, IndiaTata Memorial Centre, Homi Bhabha National Institute, Mumbai, IndiaTata Memorial Centre, Homi Bhabha National Institute, Mumbai, IndiaTata Memorial Centre, Homi Bhabha National Institute, Mumbai, IndiaPURPOSEBreast cancer (BC) is the most common malignancy among women in India and globally. Given the high survivorship, understanding the evolution of health-related quality of life (HRQoL) is crucial, yet comprehensive longitudinal studies from India are lacking.PATIENTS AND METHODSThis prospective observational study included 500 patients with BC registered between June 2019 and March 2022. HRQoL was assessed at pretreatment, treatment completion, and 6-month follow-up using European Organisation for Research and Treatment of Cancer (EORTC)-QLQ-C30, EORTC-QLQ-BR-23, and EQ-5D-5L tools. A linear mixed-effects model analyzed HRQoL trajectories and predictors.RESULTSThe median patient age was 46 years, with 60.8% presenting with locally advanced disease; all patients underwent multimodal therapy, comprising surgery (57% mastectomy), chemotherapy (95%), and radiotherapy (RT; 77%). Pretreatment global QoL scores were influenced by age (younger fared better, P = .003), stage (P = .027), and social displacement (P = .038). Longitudinal assessment revealed a small decline in global QoL (–2.1) and EQ-VAS (–1.9), along with meaningful improvements in social (+12.8), cognitive (+4.3), and role function (+7.3). Symptom burden significantly decreased, except for deterioration in body image (–7) and sexual enjoyment (–16). Younger patients had slower recovery in physical (P = .003) and social function (P = .05), while school education and financial independence positively influenced QoL variation. Social displacement affected trajectories of QoL (P = .017), role (P = .032), and social function (P = .024). Extent of surgery and RT did not affect overall HRQoL trends, although RT recipients reported more fatigue (P = .029).CONCLUSIONTo our knowledge, this is the first longitudinal HRQoL study in Indian patients with BC, showing significant improvement in most functional domains at early survivorship. Sociodemographic factors, such as age, social displacement, education, and financial independence, rather than treatment modalities, were stronger predictors of HRQoL. Longer follow-up is needed for a more comprehensive assessment.https://ascopubs.org/doi/10.1200/GO-24-00507
spellingShingle Suman Ghosh
Tabassum Wadasadawala
Sanjay Mohanty
Rajiv Sarin
Vani Parmar
Sudeep Gupta
Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
JCO Global Oncology
title Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
title_full Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
title_fullStr Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
title_full_unstemmed Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
title_short Temporal Evolution in Patient-Reported Outcomes in Indian Women With Breast Cancer: A Longitudinal Study
title_sort temporal evolution in patient reported outcomes in indian women with breast cancer a longitudinal study
url https://ascopubs.org/doi/10.1200/GO-24-00507
work_keys_str_mv AT sumanghosh temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy
AT tabassumwadasadawala temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy
AT sanjaymohanty temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy
AT rajivsarin temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy
AT vaniparmar temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy
AT sudeepgupta temporalevolutioninpatientreportedoutcomesinindianwomenwithbreastcanceralongitudinalstudy